Theravance Biopharma, Inc.

8-K Entered a material agreement; Regulation FD disclosure; Other events Jun 29, 2026 8-K Director or officer change Jun 23, 2026 8-K Shareholder vote results Jun 12, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release) May 7, 2026 8-K Other events Mar 30, 2026 10-K Fiscal year ended 2025-12-31 Mar 23, 2026 8-K Results of operations (earnings release) Mar 19, 2026 8-K Results of operations (earnings release); Exit or disposal costs; Regulation FD disclosure Mar 3, 2026 8-K Regulation FD disclosure Jan 12, 2026 8-K Other events Dec 8, 2025 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Results of operations (earnings release) Nov 10, 2025 8-K Other events Aug 25, 2025 8-K Other events Aug 20, 2025 10-Q Quarter ended 2025-06-30 Aug 13, 2025 8-K Results of operations (earnings release) Aug 12, 2025 8-K Other events Jun 26, 2025 8-K Other events Jun 6, 2025 8-K Entered a material agreement; Completed an acquisition or disposition; Regulation FD disclosure Jun 2, 2025 8-K Shareholder vote results May 20, 2025 10-Q Quarter ended 2025-03-31 May 12, 2025 8-K Results of operations (earnings release) May 8, 2025 10-K Fiscal year ended 2024-12-31 Mar 7, 2025 8-K Results of operations (earnings release) Feb 26, 2025 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Results of operations (earnings release) Nov 12, 2024 8-K Other events Sep 23, 2024 8-K Regulation FD disclosure Sep 10, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release) Aug 5, 2024 10-Q Quarter ended 2024-03-31 May 15, 2024 8-K Results of operations (earnings release) May 13, 2024 8-K Shareholder vote results May 9, 2024 10-K Fiscal year ended 2023-12-31 Mar 1, 2024 8-K Other events Feb 28, 2024 8-K Results of operations (earnings release) Feb 26, 2024 8-K Other events Jan 16, 2024 8-K Other events Jan 5, 2024 8-K Other events Dec 28, 2023